pra, whitepaper, human, liability, clinical trials

Download: Expert Solutions for Human Abuse Liability Trials

Human abuse liability data is now considered a critical piece of information during the new drug application (NDA) review process for most treatments involving central nervous system (CNS) indications and those with abuse deterrent or tamper resistant properties. As a global strategic partner for pharmaceutical and biotech companies in Phase I development, PRA’s Early Development Services (EDS) team is highly …